Health

EU backs AstraZeneca drug for Covid treatment

September 16, 2022 | 01:41 p.m EDT

London: AstraZeneca's Evusheld drug has been recommended for marketing in the European Union to treat patients at risk of death from Covid, the British pharmaceutical group said Friday.

The EU's drug watchdog had already approved Evusheld for the prevention of coronavirus in such patients.

"Evusheld long-acting antibody combination" has been "recommended for approval in the EU for the treatment of Covid-19", AstraZeneca said in a statement.

Its use via injection is recommended for adults and children aged 12 and above "who are at increased risk of progressing to severe Covid‑19", it added.

The European Medicines Agency's latest Evusheld recommendation followed trials showing "significant protection against progression to severe Covid-19 or death".

September 16, 2022 01:41 PM

Opinion

Music and civilization

Opinion

Indeed, we are in need!

The Zionist entity’s carte blanche

By Nejoud Al-Yagout Recently, in Amsterdam, there were clashes between Zionist football hooligans and Palestinians. Depending on which news network you believe, the blame was thrust on either the Zionists or the Palestinians. Interestingly enough, a...

Keep smiling

By Hassan T Bwambale World Kindness Day is an international observance of kindness every November 13. It was introduced in Japan in 1998 by the World Kindness Movement. A smile is among the acts of kindness. Smiling has a great effect on a person’...